PRESS RELEASE published on 09/29/2023 at 23:00, 1 year 1 month ago Abivax files registration statement for proposed initial public offering in the United States
PRESS RELEASE published on 09/29/2023 at 18:00, 1 year 1 month ago Abivax announces the release of its 2023 half-year financial report
PRESS RELEASE published on 09/21/2023 at 18:00, 1 year 2 months ago Abivax presents first-half 2023 financial results
PRESS RELEASE published on 09/07/2023 at 08:00, 1 year 2 months ago Abivax provides business and operational update
PRESS RELEASE published on 08/23/2023 at 18:00, 1 year 2 months ago Abivax appoints Patrick Malloy as Senior Vice President Investor Relations
PRESS RELEASE published on 08/21/2023 at 08:00, 1 year 3 months ago Abivax secures up to EUR 150M from two structured debt financing transactions
PRESS RELEASE published on 08/10/2023 at 18:00, 1 year 3 months ago Abivax announces plans to conduct registered public offering in the United States
PRESS RELEASE published on 08/02/2023 at 18:00, 1 year 3 months ago ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANE) WITH A NOMINAL VALUE OF EUR 24,999,975.99
PRESS RELEASE published on 07/11/2023 at 18:00, 1 year 4 months ago Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors
PRESS RELEASE published on 06/15/2023 at 22:41, 1 year 5 months ago Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023
Published on 11/21/2024 at 22:05, 2 hours 14 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 2 hours 29 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 4 hours 4 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 4 hours 9 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 5 hours 18 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 5 hours 43 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 6 hours 21 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 6 hours 28 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 6 hours 28 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 17 hours 21 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 6 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 16 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
